Sartorius acquires WaterSep BioSeparations

By The Science Advisory Board staff writers

December 11, 2020 -- Sartorius Stedim Biotech has acquired WaterSep BioSeparations for approximately $27 million plus an earn-out based on sales revenues through 2023 of up to $9 million. The transaction adds to Sartorius' filtration units for bioprocessing devices.

WaterSep BioSeparations is a privately owned company based in Malborough, MA, which employs 15 people and is on track to earn revenue of approximately $2.5 million in 2020. The company develops, manufactures, and markets hollow-fiber membrane devices (crossflow filtration) and presterilized assemblies for upstream and downstream biopharmaceutical applications.

If you like this content, please share it with a colleague!